Atalanta Sosnoff Capital, LLC Boston Scientific Corp Transaction History

Atalanta Sosnoff Capital, LLC

$4.33 Billion
Q1 2024

A detailed history of Atalanta Sosnoff Capital, LLC transactions in Boston Scientific Corp stock. As of the latest transaction made, Atalanta Sosnoff Capital, LLC holds 755,714 shares of BSX stock, worth $57.7 Million. This represents 1.2% of its overall portfolio holdings.

Number of Shares

755,714

Previous 731,171 3.36%

Holding current value

$57.7 Million

Previous $42.3 Million 22.45%

% of portfolio

1.2%

Previous 1.09%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$57.6 - $68.62 $1.41 Million - $1.68 Million	24,543 Added 3.36%	755,714 $51.8 Million
Q4 2023 Feb 12, 2024	SELL	$48.64 - $57.81 $556,149 - $660,999	-11,434 Reduced 1.54%	731,171 $42.3 Million
Q3 2023 Nov 13, 2023	SELL	$50.19 - $54.68 $1.06 Million - $1.15 Million	-21,108 Reduced 2.76%	742,605 $39.2 Million
Q2 2023 Aug 07, 2023	SELL	$49.72 - $54.64 $16.1 Million - $17.7 Million	-324,351 Reduced 29.81%	763,713 $41.3 Million
Q1 2023 May 11, 2023	SELL	$45.09 - $50.03 $962,761 - $1.07 Million	-21,352 Reduced 1.92%	1,088,064 $54.4 Million

Q4 2022 May 22, 2023	BUY	$39.56 - $47.22 $428,593 - $511,581	10,834 Added 1.0%	1,098,898 $50.9 Million
Q4 2022 Feb 09, 2023	SELL	$39.56 - $47.22 $520,609 - $621,415	-13,160 Reduced 1.17%	1,109,416 $51.3 Million
Q3 2022 Oct 12, 2022	SELL	$36.71 - $109.66 $159,211 - $475,595	-4,337 Reduced 0.38%	1,122,576 $43.5 Million
Q2 2022 Jul 14, 2022	SELL	$35.24 - $47.1 $978,509 - $1.31 Million	-27,767 Reduced 2.4%	1,126,913 $42 Million
Q1 2022 Apr 11, 2022	BUY	$40.9 - $45.1 $1.58 Million - $1.74 Million	38,621 Added 3.46%	1,154,680 $51.1 Million
Q4 2021 Jan 25, 2022	SELL	$38.07 - $44.87 $11.4 Million - $13.4 Million	-298,613 Reduced 21.11%	1,116,059 $47.4 Million
Q3 2021 Oct 14, 2021	BUY	$41.23 - $45.88 $35.8 Million - $39.8 Million	868,038 Added 158.8%	1,414,672 $61.4 Million
Q2 2021 Jul 13, 2021	BUY	$38.58 - $44.24 $1.14 Million - $1.3 Million	29,479 Added 5.7%	546,634 $23.4 Million
Q1 2021 Apr 20, 2021	SELL	$35.27 - $39.67 $60,135 - $67,637	-1,705 Reduced 0.33%	517,155 $20 Million
Q4 2020 Jan 14, 2021	SELL	$33.15 - $41.97 $29 Million - $36.7 Million	-873,677 Reduced 62.74%	518,860 $18.7 Million
Q3 2020 Oct 14, 2020	SELL	$34.44 - $42.23 $1.37 Million - $1.68 Million	-39,683 Reduced 2.77%	1,392,537 $53.2 Million
Q2 2020 Jul 21, 2020	SELL	$30.19 - $39.11 $14 Million - $18.1 Million	-463,369 Reduced 24.44%	1,432,220 $50.3 Million
Q1 2020 Apr 16, 2020	BUY	$25.83 - $45.71 $10.7 Million - $19 Million	415,093 Added 28.04%	1,895,589 $61.9 Million
Q4 2019 Jan 23, 2020	SELL	$37.87 - $45.37 $709,115 - $849,553	-18,725 Reduced 1.25%	1,480,496 $66.9 Million
Q3 2019 Oct 15, 2019	BUY	$40.31 - $43.45 $12.4 Million - $13.3 Million	306,933 Added 25.74%	1,499,221 $61 Million
Q2 2019 Jul 15, 2019	SELL	$34.91 - $42.98 $1.15 Million - $1.42 Million	-32,961 Reduced 2.69%	1,192,288 $51.2 Million
Q1 2019 Apr 09, 2019	BUY	$32.91 - $40.75 $306,688 - $379,749	9,319 Added 0.77%	1,225,249 $47 Million
Q4 2018 Jan 09, 2019	SELL	$31.73 - $39.04 $306,733 - $377,399	-9,667 Reduced 0.79%	1,215,930 $43 Million
Q3 2018 Oct 10, 2018	SELL	$32.83 - $38.63 $704,367 - $828,806	-21,455 Reduced 1.72%	1,225,597 $47.2 Million
Q2 2018 Jul 11, 2018	BUY	$26.84 - $34.32 $859,121 - $1.1 Million	32,009 Added 2.63%	1,247,052 $40.8 Million
Q1 2018 Apr 06, 2018	BUY	$25.2 - $28.54 $575,996 - $652,338	22,857 Added 1.92%	1,215,043 $33.2 Million
Q4 2017 Jan 09, 2018	SELL	$24.79 - $29.8 $651,778 - $783,501	-26,292 Reduced 2.16%	1,192,186 $29.6 Million
Q3 2017 Oct 10, 2017	BUY	$26.26 - $29.17 $32 Million - $35.5 Million	1,218,478	1,218,478 $35.5 Million

Others Institutions Holding BSX

# of Institutions

1,323

Shares Held

1.17B

Call Options Held

5.92M

Put Options Held

5.75M

View Full List

About BOSTON SCIENTIFIC CORP

Ticker BSX
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,431,609,984
Market Cap $109B
Description
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...

More about BSX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Atalanta Sosnoff Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Atalanta Sosnoff Capital, LLC with notifications on news.

Account

Atalanta Sosnoff Capital, LLC Boston Scientific Corp Transaction History